SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-24-005364
Filing Date
2024-01-22
Accepted
2024-01-22 06:35:52
Documents
37

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2321853-14_s1a.htm S-1/A 3396969
2 EXHIBIT 1.1 tm2321853d16_ex1-1.htm EX-1.1 184768
3 EXHIBIT 5.1 tm2321853d16_ex5-1.htm EX-5.1 10383
4 EXHIBIT 10.3 tm2321853d16_ex10-3.htm EX-10.3 237725
5 EXHIBIT 10.4 tm2321853d16_ex10-4.htm EX-10.4 55409
6 EXHIBIT 23.1 tm2321853d16_ex23-1.htm EX-23.1 2550
7 EX-FILING FEES tm2321853d16_ex-filingfees.htm EX-FILING FEES 20471
8 GRAPHIC lg_arrivent-4c.jpg GRAPHIC 11978
9 GRAPHIC bc_stagedev-4c.jpg GRAPHIC 78548
10 GRAPHIC tb_patient-4c.jpg GRAPHIC 58364
11 GRAPHIC pc_cancercases-4c.jpg GRAPHIC 52304
12 GRAPHIC pc_confidential-4c.jpg GRAPHIC 32944
13 GRAPHIC tb_agents-4c.jpg GRAPHIC 64395
14 GRAPHIC fc_egfr-4c.jpg GRAPHIC 84119
15 GRAPHIC tb_drug-4c.jpg GRAPHIC 31487
16 GRAPHIC fc_cohort-4c.jpg GRAPHIC 86044
17 GRAPHIC fc_arm-4c.jpg GRAPHIC 118564
18 GRAPHIC lc_plasamconcent-4c.jpg GRAPHIC 56296
19 GRAPHIC lc_invivo01-4c.jpg GRAPHIC 39924
20 GRAPHIC lc_invivo02-4c.jpg GRAPHIC 38183
21 GRAPHIC lc_baf301-4c.jpg GRAPHIC 36004
22 GRAPHIC lc_baf302-4c.jpg GRAPHIC 40593
23 GRAPHIC lc_baf303-4clr.jpg GRAPHIC 38742
24 GRAPHIC lc_baf304-4c.jpg GRAPHIC 42254
25 GRAPHIC tb_treatment-4c.jpg GRAPHIC 67254
26 GRAPHIC tb_confirmedorr-4c.jpg GRAPHIC 108067
27 GRAPHIC bc_treatment-4c.jpg GRAPHIC 77476
28 GRAPHIC bc_treated-4clr.jpg GRAPHIC 86880
29 GRAPHIC tb_overviewtrae-4c.jpg GRAPHIC 80658
30 GRAPHIC tb_preferred-4c.jpg GRAPHIC 78997
31 GRAPHIC fc_combination-4c.jpg GRAPHIC 74878
32 GRAPHIC tb_character-4c.jpg GRAPHIC 57943
33 GRAPHIC lc_median-4clr.jpg GRAPHIC 68853
34 GRAPHIC fc_acrylamide-4clr.jpg GRAPHIC 58000
35 GRAPHIC ph_egfr-4c.jpg GRAPHIC 115583
36 GRAPHIC tm2321853d16_ex5-1img002.jpg GRAPHIC 2274
37 GRAPHIC tm2321853d16_ex5-1img001.jpg GRAPHIC 1159
  Complete submission text file 0001104659-24-005364.txt   6342885
Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent Biopharma, Inc. (Filer) CIK: 0001868279 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-276397 | Film No.: 24547042
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)